New Jersey Patent of the Month – February 2025
electroCore, Inc. has pioneered a breakthrough in non-invasive neuromodulation, redefining the treatment landscape for conditions like migraines and cluster headaches. Their latest innovation leverages transcutaneous electrical nerve stimulation (tVNS) to target the vagus nerve without requiring surgical implantation, setting a new standard in patient-friendly therapeutic interventions.
This method involves placing a stimulator on the outer skin surface, which then delivers controlled electrical impulses to the vagus nerve. The system captures and transmits real-time treatment data, enabling both patients and healthcare providers to monitor efficacy. By integrating wireless connectivity, the device can relay user status data to a mobile application, offering insights into headache severity and treatment response. This allows for data-driven adjustments to therapy regimens, optimizing patient outcomes.
Unlike invasive neuromodulation techniques, electroCore’s approach eliminates the risks and recovery times associated with surgery. The device is designed to deliver precise electrical impulses for durations ranging from 30 seconds to 5 minutes per session, with customizable therapy schedules. Additionally, it records physiological parameters such as heart rate and blood pressure, enhancing personalized treatment strategies.
Beyond migraines, this technology holds promise for other conditions influenced by vagus nerve activity, including anxiety and inflammatory disorders. Its potential extends to broader healthcare applications, demonstrating electroCore’s commitment to advancing neuromodulation.
By combining cutting-edge science with user-centric design, electroCore’s innovation is transforming pain management and neurological care. This non-invasive, data-driven approach represents a significant step forward in harnessing bioelectronic medicine to improve quality of life for patients worldwide.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
